Anavex Life Sciences Corp. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
BLACKROCK, INC. | 02/07/2025 | 6.55 M | $70.37 M | -2.80% | 7.73% |
VANGUARD GROUP INC | 02/11/2025 | 4.68 M | $50.27 M | -1.26% | 5.52% |
STATE STREET CORP | 02/14/2025 | 2.41 M | $25.90 M | -21.33% | 2.89% |
GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 1.87 M | $20.14 M | -0.44% | 2.21% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 1.13 M | $12.19 M | 375.95% | 1.36% |
MORGAN STANLEY | 02/14/2025 | 904.16 K | $9.71 M | 25.83% | 1.08% |
NWAM LLC | 02/05/2025 | 913.05 K | $9.81 M | 0.28% | 1.08% |
TWO SIGMA INVESTMENTS, LP | 02/14/2025 | 776.90 K | $8.34 M | -6.47% | 0.93% |
NORTHERN TRUST CORP | 02/14/2025 | 706.90 K | $7.59 M | 1.57% | 0.85% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 677.22 K | $7.27 M | 1.69% | 0.80% |
INVESCO LTD. | 02/13/2025 | 615.05 K | $6.61 M | 2,419.76% | 0.74% |
GOLDMAN SACHS GROUP INC | 02/11/2025 | 538.54 K | $5.78 M | -18.66% | 0.64% |
TWO SIGMA ADVISERS, LP | 02/14/2025 | 490.60 K | $5.27 M | -0.59% | 0.59% |
PIER CAPITAL, LLC | 02/11/2025 | 441.92 K | $4.75 M | 100.00% | 0.52% |
UBS GROUP AG | 02/14/2025 | 418.76 K | $4.50 M | 221.99% | 0.50% |
ESSENTIAL PLANNING, LLC. | 02/10/2025 | 413.09 K | $3.25 M | 100.00% | 0.49% |
CITADEL ADVISORS LLC | 02/14/2025 | 372.50 K | $4.00 M | 39.57% | 0.45% |
SCULPTOR CAPITAL LP | 02/14/2025 | 371.40 K | $3.99 M | 0.00% | 0.45% |
SCULPTOR CAPITAL LP | 02/14/2025 | 370.10 K | $3.97 M | -0.08% | 0.44% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 277.90 K | $2.98 M | 47.35% | 0.33% |
CITADEL ADVISORS LLC | 02/14/2025 | 240.91 K | $2.59 M | 843.80% | 0.29% |
BANK OF NEW YORK MELLON CORP | 02/04/2025 | 220.25 K | $2.37 M | -2.10% | 0.26% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 213.60 K | $2.29 M | 10.22% | 0.26% |
RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 213.20 K | $2.29 M | -12.55% | 0.26% |
MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 207.78 K | $2.23 M | -39.07% | 0.25% |
BANK OF AMERICA CORP /DE/ | 02/14/2025 | 198.78 K | $2.13 M | -27.79% | 0.24% |
NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 178.97 K | $1.92 M | 0.00% | 0.21% |
WOLVERINE TRADING, LLC | 02/14/2025 | 157.70 K | $1.74 M | 399.05% | 0.19% |
WELLINGTON MANAGEMENT GROUP LLP | 02/12/2025 | 158.67 K | $1.70 M | 100.00% | 0.19% |
HEARTLAND ADVISORS INC | 02/12/2025 | 155.85 K | $1.67 M | 100.00% | 0.18% |
JUMP FINANCIAL, LLC | 02/13/2025 | 153.23 K | $1.65 M | 100.00% | 0.18% |
BARCLAYS PLC | 02/13/2025 | 148.80 K | $1.60 M | -4.11% | 0.18% |
MARSHALL WACE, LLP | 02/13/2025 | 141.12 K | $1.52 M | 100.00% | 0.17% |
RHUMBLINE ADVISERS | 01/30/2025 | 123.70 K | $1.33 M | 2.91% | 0.15% |
ALLIANCEBERNSTEIN L.P. | 02/12/2025 | 115.20 K | $1.24 M | 6.82% | 0.14% |
D. E. SHAW & CO., INC. | 02/14/2025 | 105.13 K | $1.13 M | 100.00% | 0.13% |
JANE STREET GROUP, LLC | 02/14/2025 | 104.70 K | $1.12 M | 67.74% | 0.13% |
WELLS FARGO & COMPANY/MN | 02/13/2025 | 101.47 K | $1.09 M | -22.42% | 0.12% |
COMMONWEALTH EQUITY SERVICES, LLC | 02/10/2025 | 102.66 K | $1.10 M | 7.64% | 0.12% |
LPL FINANCIAL LLC | 02/11/2025 | 93.90 K | $1.01 M | 36.38% | 0.11% |
CITIGROUP INC | 02/12/2025 | 93.48 K | $1.00 M | 53.75% | 0.11% |
VIRTU FINANCIAL LLC | 02/11/2025 | 90.03 K | $967.00 K | 100.00% | 0.11% |
HIKARI POWER LTD | 02/04/2025 | 85.59 K | $919.00 K | 0.00% | 0.10% |
CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. | 02/14/2025 | 83.35 K | $895.00 K | 311.12% | 0.10% |
PVG ASSET MANAGEMENT CORP | 02/21/2025 | 78.49 K | $842.98 K | 503.54% | 0.09% |
CARNEGIE CAPITAL ASSET MANAGEMENT, LLC | 01/15/2025 | 76.78 K | $824.60 K | 4.70% | 0.09% |
RAFFERTY ASSET MANAGEMENT, LLC | 02/14/2025 | 74.60 K | $801.22 K | -46.56% | 0.09% |
TREXQUANT INVESTMENT LP | 02/12/2025 | 71.47 K | $767.63 K | 26.81% | 0.08% |
ALPS ADVISORS INC | 02/13/2025 | 68.57 K | $736.40 K | 7.17% | 0.08% |
SQUAREPOINT OPS LLC | 02/14/2025 | 67.63 K | $726.31 K | 304.88% | 0.08% |
Anavex Life Sciences Corp. institutional Ownership - FAQ's
During the previous two years, 67 institutional investors and hedge funds held shares of Anavex Life Sciences Corp.. The most heavily invested institutionals were:
MILLENNIUM MANAGEMENT LLC: 340,019
Creative Planning: 50,403
ADAR1 Capital Management, LLC: 16,221
XTX Topco Ltd: 0
VICTORY CAPITAL MANAGEMENT INC: 0
TUDOR INVESTMENT CORP ET AL: 0
34.83% of Anavex Life Sciences Corp. stock is owned by institutional investors.
Institutional investors have bought a total of 14.50 M shares in the last 24 months. This purchase volume represents approximately $120.65 M in transactions.